A Randomised Controlled Trial of the Use of Aciclovir And/Or Prednisolone for the Early Treatment of Bell’S Palsy: the BELLS Study
Total Page:16
File Type:pdf, Size:1020Kb
Health Technology Assessment 2009; Vol. 13: No. 47 A randomised controlled trial of the use of aciclovir and/or prednisolone for the early treatment of Bell’s palsy: the BELLS study FM Sullivan, IRC Swan, PT Donnan, JM Morrison, BH Smith, B McKinstry, RJ Davenport, LD Vale, JE Clarkson, R Hernández, K Stewart, V Hammersley, S Hayavi, A McAteer, D Gray and F Daly October 2009 DOI: 10.3310/hta13470 Health Technology Assessment NIHR HTA programme www.hta.ac.uk HTA How to obtain copies of this and other HTA programme reports An electronic version of this publication, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable CD-ROM is also available (see below). Printed copies of HTA monographs cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our Despatch Agents. Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph. You can order HTA monographs from our Despatch Agents: – fax (with credit card or official purchase order) – post (with credit card or official purchase order or cheque) – phone during office hours (credit card only). Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. Contact details are as follows: HTA Despatch Email: [email protected] c/o Direct Mail Works Ltd Tel: 02392 492 000 4 Oakwood Business Centre Fax: 02392 478 555 Downley, HAVANT PO9 2NP, UK Fax from outside the UK: +44 2392 478 555 NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30–40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can be purchased only for the current or forthcoming volume. Payment methods Paying by cheque If you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit card The following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase order You can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD? Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide. The website also provides information about the HTA programme and lists the membership of the various committees. AbstractOutcomeAppendix .............................................................dependent 12 .on.the.time.delay.to.. iii commencementRecruiters’ notes.of. treatment......................................... ................. 43 . 97 ContentsOutcome .............................................................dependent.on.severity.at.onset. .... v44 Assessors’Appendix. concordance13 . ............................... 44 A randomised controlled trial of the List of abbreviationsWeekly recruitment .......................................... update (example). vii..... 99 Chapter 7 use of aciclovir and/or prednisolone for ExecutiveDiscussionAppendix summary 14................................................... ........................................... .ix47 StrengthsBriefing.and .noteslimitations for researchers.of.the.study .................... ........ 47 .103 the early treatment of Bell’s palsy: the ChapterImplications 1 .for.practice. ............................. 48 BackgroundAppendix 15................................................ 1 BELLS study ChapterDisease Form8. condition C ......................................................... ........................................ 1 .107 ProvenanceConclusion.of ...................................................the.Scottish.Bell’s.Palsy.Study . 49 1 GovernanceAppendix .16................................................. 1 ChapterApprovals Form9 . .................................................... B ......................................................... 1 .109 1* 2 3 StudyOpportunities.calendar. ............................................for further research ............. 251 FM Sullivan, IRC Swan, PT Donnan, PrimaryAppendix.research 17 . ......................................... 51 JM Morrison,4 BH Smith,5 B McKinstry,6 ChapterEvidence 2House–Brackmann .synthesis. ...................................... Assessors ..................... 51 .111 7 8,9 10 Methods ...................................................... 3 RJ Davenport, LD Vale, JE Clarkson, AcknowledgementsReferrersAppendix. ..................................................... 18 ........................................... 353 9 11 6 RecruitersHealth. .................................................... Utilities Index Mark 3 ..................... 5 .113 R Hernández, K Stewart, V Hammersley, ReferencesPatients. .................................................................................................................. 655 4 5 5 3 InterventionsAppendix 19. .............................................. 6 S Hayavi, A McAteer, D Gray and F Daly AppendixIdentificationBrief 1 Pain.of .Inventorycoded.treatments .................................... ............. 7 .119 1 ResearchersBELLS protocol. ................................................. ............................................ 757 Scottish School of Primary Care, University of Dundee, UK AssessorsAppendix. ..................................................... 20 . 9 2Department of Otolaryngology, University of Glasgow, UK AppendixObjectivesDerriford 2 . .................................................... Appearance Scale (DAS59). .......9 .123 3Community Health Sciences, University of Dundee, UK PrimaryTrial Steering.outcomes Committee. ....................................... ........................... 967 4Division of Community Based Sciences, University of Glasgow, UK SecondaryAppendix.outcomes 21 . ................................... 10 5Centre of Academic Primary Care, University of Aberdeen, UK AppendixPatient 3 deaths on the BELLS study Methods.used.to.enhance.the.quality.of.measurements........... .127 6Community Health Sciences, University of Edinburgh, UK Data.............................................................. Monitoring and Ethics Committee11 (DMEC) 7 69Appendix 22 Department of Clinical Neurosciences, University of Edinburgh, UK ChapterDATA 3CONSORT .MONITORING Checklist.AND of .itemsETHICS to .includeCOMMITTEE when 8Health Services Research Unit, University of Aberdeen, UK Study.............................................................. reportingdesign ............................................... a randomised trial ......................71. 13 .129 9Health Economics Research Unit, University of Aberdeen, UK SampleREPORT.size.TEMPLATE. ..................................................1. .............................. .1371 10Dental Health Services Research Unit, University of Dundee, UK ExplanationDATAHealth.MONITORING Technology.of.any.interim Assessment.AND.analyses.ETHICS reports.and.COMMITTEE.stopping published.rules to 11St John’s Hospital, Livingston, UK ............................................................................................................................date .............................................................1372 .131 RandomisationREPORT.TEMPLATE. .............................................2. .............................. .1372 *Corresponding author SubgroupHealth Technology.analyses. ...................................... Assessment . 14 Appendixprogramme 4 ................................................. .151 ChapterBELLS 4 Study Management Committee ..... 75 Declared competing interests of authors: none Results ........................................................ 15 AppendixParticipant 5 .flow. ........................................... 15 ProtocolTimetable.deviations of approvals.from. study................................as.planned,.together. 77 .with. Published October 2009 reasons. .................................................... 15 DOI: 10.3310/hta13470 AppendixRecruitment 6 . ................................................ 15 BaselineHow cruel.data to. ............................................... call it Bell’s palsy . 18 Outcomesby Graeme.and.estimation Garden. ........................... ............... 1881 This report should be referenced as follows: Ancillary.analyses. ........................................ 25 AppendixAdverse 7.events .and.side.effects. .................. 26 Sullivan FM, Swan IRC, Donnan PT, Morrison JM, Smith BH, McKinstry B, et al. A Local Principal Investigators ...................... 83 randomised controlled trial of the use of aciclovir and/or prednisolone for the early Chapter 5 treatment of Bell’s palsy: the BELLS study. Health Technol Assess 2009;13(47). AppendixEconomic 8 evaluation of treatments ........... 27 IntroductionScottish Bell’s. ................................................ Palsy Study: ‘BELLS’ ............. .2785 Health Technology Assessment is indexed and abstracted in Index Medicus/MEDLINE, Aim. ............................................................